The company was founded in 2019 and operates within the Biotechnology and Manufacturing industries. It is headquartered in the United States. A.D.A.M. secured its €3.00M Late-seed investment at 16 July 2024, with funding from Presto Ventures and Brighteye. This investment signifies a strong support and belief in the innovative biotech capabilities of A.D.A.M., particularly in the field of 3D-bioprinting for creating on-demand bone implants.
A.D.A.M.
A.D.A.M. is a biotech company that specializes in on-demand 3D-bioprinting with a primary focus on bone implants.
Founded 2019
Stamford, United States
17 employees
Venture round
Total: $558.35K
Biotechnology, Manufacturing +2
Stamford, United States
17 employees
Venture round
Total: $558.35K
Biotechnology, Manufacturing +2
General Information
Company Name
A.D.A.M.
Founded Year
2019
Location
Stamford, United States
Stamford, United States
Employees
17
Industries
Biotechnology, Manufacturing, VR/AR +1
Funding Stage
Venture round
BounceWatch is an independent company data service, not affiliated with A.D.A.M.. To contact A.D.A.M., visit adambioprinting.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About A.D.A.M.
Taxonomy: Biotech, 3D-bioprinting, Bone implants, Tissue manufacturing, Personalized medicine, Medical device production, Point-of-care, Implant manufacturing, Hospital technology, Medical innovation, On-demand manufacturing, Bioprinted tissues, Organ manufacturing, Advanced manufacturing
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 1 |
Mount Sinai Innovation Partners
|
01 Apr 2022 |
| Seed Round | $558.35K | - |
|
14 Jun 2021 |
| Seed Round | Undisclosed | 1 |
|
01 Dec 2018 |
Latest News
View All
A.D.A.M. Alternatives & Competitors
View All Alternatives
A.D.A.M. vs
Pioneering biotech solutions to restore and enhance tissue and organ health.
Venture round
2 employees
Biotechnology, Manufacturing
A.D.A.M. vs
REGEMAT 3D
Spain
Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures.
Equity Crowdfunding
25 employees
Biotechnology, Manufacturing
A.D.A.M. vs
Meticuly
Thailand
Personalised Medical Implant Solutions for Better Lives.
Series A
48 employees
Health Care, Health and Wellness
FAQ About A.D.A.M.
A.D.A.M. is a biotech company that specializes in on-demand 3D-bioprinting with a primary focus on bone implants.
A.D.A.M. was founded in 2019.
A.D.A.M. is headquartered in Stamford, United States.
A.D.A.M. operates in Biotechnology, Manufacturing, VR/AR and 3D Printing. Its work centres on Biotech, 3D-bioprinting, Bone implants and Tissue manufacturing.
A.D.A.M. has approximately 17 employees.
A.D.A.M. has completed 3 funding rounds, raising a total of $558.35K. The latest funding stage is Venture round.
Top alternatives and competitors to A.D.A.M. include Grandhope Biotech Co., Ltd., REGEMAT 3D, Meticuly, Allevi by 3D Systems, Gramercy Extremity Orthopedics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
A.D.A.M. and Grandhope Biotech Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for A.D.A.M., https://bouncewatch.com/company/adam, updated 30 December 2024. When citing, please name BounceWatch and link this page.
